Transgene competitorsClear all

EpiVax's top competitors include Magenta Therapeutics, Synthace and ProtoKinetix.
EpiVax
EpiVax
EpiVax has developed comprehensive analytical capabilities in the field of computational immunology.
Magenta Therapeutics
Magenta Therapeutics
Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.
Synthace
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
ProtoKinetix
ProtoKinetix
ProtoKinetix is a bio-technology company that provides medical researchers with a platform for enhancing cell survival and health, both in vitro and in vivo.
Founding Date
Founding Date
1998
Founding Date
2016
Founding Date
2011
Founding Date
1999
Type
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Providence, US HQ
Locations
Cambridge, US HQ
Locations
London, GB HQ
Cambridge, US
Locations
Marietta, US HQ
Employees
Employees
32
Employees
72
Employees
781% increase
Employees
N/A
Valuation ($)
Valuation ($)
N/A
Valuation ($)
317.4 m
Valuation ($)
N/A
Valuation ($)
25.3 m
Twitter followers
Twitter followers
379
Twitter followers
2 k
Twitter followers
1.6 k
Twitter followers
153
Number of tweets (last 30 days)
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
30
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
7.7
Average likes per tweet (last 30 days)
2.1
Average likes per tweet (last 30 days)
2.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
76.67%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
361738
Alexa Website Rank
429432
Alexa Website Rank
523161
Alexa Website Rank
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£581 (FY, 2013)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($76.8m) (FY, 2019)
Net income
(£361.6k) (FY, 2013)
Net income
($4.2m) (FY, 2019)

Funding

Latest funding round
Latest funding round
$ 55k (about 8 years ago)
Latest funding round
N/A
Latest funding round
$ 25.6m (almost 2 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 3.2m
Total funding raised
$ 150.5m
Total funding raised
$ 41.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Magenta Therapeutics
HQ
Cambridge, US
Employees
72

Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.

View company
Synthace
HQ
London, GB
Employees
78↑ 1% increase

Synthace produces bio-based chemical products through the application of synthetic biology.

View company
ProtoKinetix
HQ
Marietta, US

ProtoKinetix is a bio-technology company that provides medical researchers with a platform for enhancing cell survival and health, both in vitro and in vivo.

View company